# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Apogee Enterprises shines in Q4 FY24, surpassing expectations with robust sales growth of 5.2% year-on-year, reaching $361.84 m...
Companies Reporting Before The Bell • Addex Therapeutics (NASDAQ:ADXN) is estimated to report earnings for its fourth quarter.
This range includes approximately 2 percentage points of decline related to fiscal 2025 reverting to a 52-week year, and approx...
Apogee Enterprises (NASDAQ:APOG) reported quarterly earnings of $1.14 per share which beat the analyst consensus estimate of $1...
Project Fortify includes the following strategic changes related to the Architectural Framing Systems (AFS) segment: Eliminatin...